UK Researchers Find “Dormant” Parasite Cysts Are Actually Quite Active
Sanders-Brown Researcher Tapped for Academic-Industry Collaborative Grant
LEXINGTON, Ky. (Sept. 8, 2015) -- Inflammation is on the research community's "Most Wanted" list as the possible culprit in many diseases, including cancer, heart disease, and rheumatoid arthritis.
New Policy for Dual Use Research Requires PI Training
On September 24, 2015 the United States Government (USG) Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (DURC), http://www.phe.gov/s3/dualuse/Documents/durcpolicy.pdf will become effective.&
New Institute of Biomedical Informatics
A new Institute of Biomedical Informatics at the University of Kentucky will integrate and leverage large data systems across the academic and medical enterprise to improve patient care, research and education. GQ Zhang, Ph.D., will join UK Aug. 1 as director of the institute. He will also serve as chief of the newly established biomedical informatics division in the UK College of Medicine and co-director of the biomedical informatics core of the UK Center for Clinical and Translational Science.
UK Behavioral Scientist Named to Prestigious NIH Grant Review Panel
UK HealthCare, Cincinnati Children's Sign Letter of Intent for Potential Pediatric Heart Care Partnership
UK HealthCare and Cincinnati Children's Hospital Medical Center have signed a Letter of Intent (LOI) to move toward a significant partnership to provide pediatric heart care services in the region.
Toxicology and Cancer Biology Open House
Students and Faculty in the Department of Toxicology and Cancer Biology held an Open House in August to meet with incoming first year graduate students. Oral and poster presentations highlighted the varied research programs in the department that investigate basic, translational and clinical aspects of toxicology and cancer biology.
Candidates invited to participate in clinical trial of UK-developed cancer treatment system
The Exatherm Total Body Hyperthermia System heats the patient’s blood to potentially damage or kill lung cancer cells throughout the body. UK is the only site in the country approved to test this new treatment in advanced lung cancer patients.
Four Students Committed to Cardiovascular Health, Education Receive Saha Awards
LEXINGTON, Ky. (Sept.